Genentech, Inc.

Genentech, Inc.

Genentech, Inc.

Overview
Date Founded

1986

Headquarters

1 DNA Way,Mailstop 258A,South San Francisco, CA 94080

Type of Company

Private

Employees (Worldwide)

11.2K

Industries

Pharmaceuticals
Industrial Machinery & Manufacturing
Biotechnology

Company Description

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Website

http://www.gene.com

Contact Data
Trying to get in touch with decision makers at Genentech, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
FiercePharma
January 11, 2021
Fierce JPM Week: Genentech CEO says partnerships, speedier trials among pandemic's 'silver linings'
FierceBiotech
January 11, 2021
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
Business Wire
January 11, 2021
Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases; - Announces strategic collaborations with Biogen, Genentech to develop RNAi therapeutics for neurodegenerative diseases -; - Founders are world-l
Nasdaq
January 5, 2021
Roche:Tiragolumab-Tecentriq Gets FDA Breakthrough Therapy Designation For Non-small Cell Lung Cancer
Business Wire
January 5, 2021
Genentech's Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Designation in Combination With Tecentriq for PD-L1-High Non-Small Cell Lung Cancer; - Tiragolumab is the first anti-TIGIT therapy to be granted Breakthrough Therapy Designation (BT

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Alexander Hardy

Chief Executive Officer

Sean Johnston

Senior Vice President & General Counsel

Levi Garraway

Director, Chief Medical Officer & Executive Vice President

Ed Harrington

Chief Financial Officer & Head of Pharma Finance North America

William N. Anderson

Chief Executive Officer, Roche Pharmaceuticals

Michael Varney

Head, Research & Early Development

Aviv Regev

Head, Research & Early Development

Nancy Vitale

Senior Vice President of Human Resources & Regional Human Resources Head, North America

Cynthia Burks

Senior Vice President, Chief People & Culture Officer, Genentech

Wendy Young

Senior Vice President, Small Molecule Drug Discovery

Board of Directors
Severin Schwan

Chief Executive Officer at Roche Holding AG

Levi Garraway

Director, Chief Medical Officer & Executive Vice President at Genentech, Inc.

Aviv Regev

Head, Research & Early Development at Genentech, Inc.

Johannes Carolus Clevers

Venture Partner at LSP Management Group BV

Andre Hoffmann

Treasurer & Director at Fondation Auxiliaire du Conservatoire botanique de la Ville de

Alan Hippe

Chief Financial & Information Technology Officer at Roche Holding AG

Alexander Hardy

Chief Executive Officer at Genentech, Inc.

William N. Anderson

Chief Executive Officer, Roche Pharmaceuticals at Genentech, Inc.

Richard P. Lifton

President at The Rockefeller University

Sean Johnston

Senior Vice President & General Counsel at Genentech, Inc.

Trending People
Page Street Publishing Co.
Author Steve Wollett's new book "God's Assassin" is a spellbinding thriller foll... - PR Newswire
The Pratt & Whitney Co., Inc.
Damage to fan blade in United Boeing 777 engine consistent with metal fatigue -N... - Nasdaq
HSBC Holdings Plc
HSBC's annual profit falls 34% as COVID-19 takes toll - Nasdaq
Trending Organizations
Page Street Publishing Co.
Author Steve Wollett's new book "God's Assassin" is a spellbinding thriller foll... - PR Newswire
The Pratt & Whitney Co., Inc.
Damage to fan blade in United Boeing 777 engine consistent with metal fatigue -N... - Nasdaq
HSBC Holdings Plc
HSBC's annual profit falls 34% as COVID-19 takes toll - Nasdaq
Paths to Genentech, Inc.
Potential Connections via
Relationship Science
You
Genentech, Inc.
Recent Transactions
Details Hidden

Genentech, Inc., Roche Holding AG purchase Jecure Therapeutics, Inc. from Versant Venture Management LLC

Details Hidden

Genentech, Inc., Roche Holding AG purchase Seragon Pharmaceuticals, Inc. from Topspin Management LLC, Aisling Capital, OrbiMed Advisors Private Equity, The Column Group LLC, venBio Partners LLC

Details Hidden

Genentech, Inc., Roche Holding AG purchase RQx Pharmaceuticals, Inc. from Avalon Ventures Management LLC, Correlation Management LLC

Transaction Advisors
Legal Advisor
Wilson Sonsini Goodrich & Rosati PC

Advised onRoche Holding AG purchases Genentech, Inc.

Investment Advisor
Goldman Sachs & Co. LLC

Advised onRoche Holding AG purchases Genentech, Inc.

Selling Group Member
Bear, Stearns & Co., Inc.

Advised onGenentech, Inc. issued USD Common Stock

Legal Advisor
Martin W. Korman

Advised onRoche Holding AG purchases Genentech, Inc.

Legal Advisor
Aaron J. Rigby

Advised onGenentech, Inc., Roche Holding AG purchase Seragon Pharmaceuticals, Inc. from Topspin Management LLC, Aisling Capital, OrbiMed Advisors Private Equity, The Column Group LLC, venBio Partners LLC

Global Co-Chairman, Mergers & Acquisitions Group
Charles M. Nathan

Advised onRoche Holding AG purchases Genentech, Inc.

Advisors & Consultants
Legal Advisor
Nathaniel P. Gallon

Co-Managing Partner, Northern California at Hogan & Lovells LLP

Legal Advisor
Kenneth Guernsey

Partner, San Francisco at Cooley LLP

Legal Advisor
David J. Berger

Partner at Wilson Sonsini Goodrich & Rosati PC
Clients
Dana-Farber Partners Cancer Care, Inc.

COORDINATION OF ONCOLOGY CLINICAL RESEARCH, EDUCATION AND PROGRAMS ACROSS DANA-FARBER, MASSACHUSETTS GENERAL HOSPITAL AND BRIGHAM AND WOMEN'S HOSPITAL
Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$3.74B
Non-Profit Donations & Grants
$100K - $250K
2020
University of Delaware

$1,000 +
2019
Cancer Foundation New Mexico

$10K - $25K
2019
The Tech Interactive

Political Donations
$250
2014
Vincent Fort

$2,000
2014
Renee S. Unterman

$1,000
2014
Ted W. Lieu

Investments
Details Hidden
Cellective Therapeutics, Inc.

Cellective Therapeutics, Inc. provides biopharmaceuticals products. It develops monoclonal antibodies for the treatment of oncology and autoimmune diseases. Cellective Therapeutics products include monoclonal antibodies that target the B-cell antigens CD19, CD20 and CD22 are in preclinical stage programs. It was founded by Thomas F. Tedder and Alter E. Geller in May, 2003 and is headquartered in Durham, NC

Details Hidden
Horizon Discovery Group PLC

Horizon Discovery Group Plc is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom.

Investors
Details Hidden
Nicolas Sommer

Professional at Genentech, Inc.

Awards & Honors
Rank #6
2017
Fortune Magazine - The 100 Best Companies to Work For
Sponsored by Fortune Magazine

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Genentech, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Genentech, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Genentech, Inc..